TY - JOUR T1 - Azithromycin in cystic fibrosis JF - European Respiratory Journal JO - Eur Respir J SP - 771 LP - 771 DO - 10.1183/09031936.05.00129304 VL - 25 IS - 4 AU - J. A. Kastelik AU - D. G. Peckham AU - S. Conway Y1 - 2005/04/01 UR - http://erj.ersjournals.com/content/25/4/771.1.abstract N2 - To the Editors: We have read with interest the article by Southern and Barker 1. The authors critically reviewed the evidence from the randomised, controlled trials of the role of azithromycin in the management of cystic fibrosis (CF). In the three randomised, controlled studies described, the effects of up to 6 months of therapy with azithromycin in CF have been reported 2–4. However, the controlled setting of randomised trials may differ … ER -